Article: New Treatment Is Breakthrough for Many Asthma Sufferers, Will Eventually Change How Allergies Are Treated, Allergists Say.

ARLINGTON HEIGHTS, Ill. -- ARLINGTON HEIGHTS, Ill., June 19 /PRNewswire/ -- A new drug expected to be approved Friday by the Food and Drug Administration (FDA) is a major treatment breakthrough for people with a serious form of allergic asthma and could eventually revolutionize how all allergic disease is treated, according to the American College of Allergy, Asthma & Immunology (ACAAI).

If approved as expected this week, anti-IgE (trade name Xolair) will initially be indicated only for patients with moderate-to-severe allergic asthma, in whom asthma attacks are triggered by an allergic reaction to things like pollen, mold, dust mites and pet dander. People with ...

Related newspaper, magazine, and journal articles:

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!